Genome & Company Market Cap

Genome & Company has a market cap or net worth of 262.77 billion as of February 6, 2026. Its market cap has increased by 181.29% in one year.

Market Cap

262.77B

Enterprise Value

251.90B

Revenue

25.95B

Ranking

n/a

PE Ratio

n/a

Stock Price

7,550.00

Market Cap Chart

Since December 26, 2018, Genome & Company's market cap has increased from 71.88B to 262.77B, an increase of 265.58%. That is a compound annual growth rate of 19.97%.

Market Cap History

Date	Market Cap	% Change
Feb 6, 2026	262.77B	10.23%
Dec 30, 2025	238.38B	179.77%
Dec 30, 2024	85.21B	-51.64%
Dec 28, 2023	176.21B	-28.34%
Dec 29, 2022	245.90B	-47.55%
Dec 30, 2021	468.83B	-55.28%
Dec 30, 2020	Upgrade Pro	Upgrade Pro
Dec 30, 2019	Upgrade Pro	Upgrade Pro
Dec 28, 2018	Upgrade Pro	Upgrade Pro
Dec 26, 2018	Upgrade Pro	Upgrade Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
S.Biomedics	379.60B
GC Cell	365.91B
NIBEC	350.61B
Y-Biologics	346.06B
ABION	306.79B
curacle co.,ltd.	260.93B
Vaxcell-Bio Therapeutics	229.78B
ISU Abxis	225.98B

Market Cap Rankings